The U.S. Food and Drug Administration has canceled a scheduled meeting of its Vaccine and Related Biological Products Advisory Committee, a decision intricately tied to recent administrative upheaval following Robert F. Kennedy Jr.’s appointment as Health and Human Services Secretary. Committee member Dr. Paul Offit confirmed the meeting, intended to decide on influenza vaccine strains for the 2025-2026 season, was called off.
About the Author
